192 related articles for article (PubMed ID: 29568406)
1. Clinicopathologic and prognostic significance of C-reactive protein/albumin ratio in patients with solid tumors: an updated systemic review and meta-analysis.
Wu J; Tan W; Chen L; Huang Z; Mai S
Oncotarget; 2018 Mar; 9(17):13934-13947. PubMed ID: 29568406
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of C-reactive protein to albumin ratio in colorectal cancer patients: a meta-analysis.
Fan Y; Xiang S; Dai Z; Zou C; Wang X; Gao Z
Int J Colorectal Dis; 2019 Jun; 34(6):1105-1111. PubMed ID: 31016379
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of the C-reactive protein to albumin ratio in colorectal cancer: an updated systematic review and meta-analysis.
Liao CK; Yu YL; Lin YC; Hsu YJ; Chern YJ; Chiang JM; You JF
World J Surg Oncol; 2021 May; 19(1):139. PubMed ID: 33933070
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of the C-reactive protein to albumin ratio in cancer: An updated meta-analysis.
Cui X; Jia Z; Chen D; Xu C; Yang P
Medicine (Baltimore); 2020 Apr; 99(14):e19165. PubMed ID: 32243358
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Role of the Pretreatment C-Reactive Protein/Albumin Ratio in Solid Cancers: A Meta-Analysis.
Li N; Tian GW; Wang Y; Zhang H; Wang ZH; Li G
Sci Rep; 2017 Jan; 7():41298. PubMed ID: 28128229
[TBL] [Abstract][Full Text] [Related]
6. Association between tumor-stroma ratio and prognosis in solid tumor patients: a systematic review and meta-analysis.
Wu J; Liang C; Chen M; Su W
Oncotarget; 2016 Oct; 7(42):68954-68965. PubMed ID: 27661111
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of the C-reactive protein to albumin ratio in esophageal cancer: A systematic review and meta-analysis.
Wang Y; Hu X; Huang Y; Xu WY; Wu YM; Li PF; Che GW
Kaohsiung J Med Sci; 2020 Jan; 36(1):54-61. PubMed ID: 31512813
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of C-reactive protein/albumin ratio in human malignancies: an updated meta-analysis.
Xu HJ; Ma Y; Deng F; Ju WB; Sun XY; Wang H
Onco Targets Ther; 2017; 10():3059-3070. PubMed ID: 28790840
[TBL] [Abstract][Full Text] [Related]
9. C-Reactive Protein to Albumin Ratio in Colorectal Cancer: A Meta-Analysis of Prognostic Value.
Zhou QP; Li XJ
Dose Response; 2019; 17(4):1559325819889814. PubMed ID: 31798355
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of pretreatment C-reactive protein/albumin ratio in nasopharyngeal carcinoma: A meta-analysis of published literature.
Yang X; Liu H; He M; Liu M; Zhou G; Gong P; Ma J; Wang Q; Xiong W; Ren Z; Li X; Zhang X
Medicine (Baltimore); 2018 Jul; 97(30):e11574. PubMed ID: 30045284
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of systemic immune-inflammation index (SII) and C-reactive protein-to-albumin ratio (CAR) in patients with esophageal cancer: a meta-analysis.
Zhang Y; Xiao G; Wang R
Cancer Manag Res; 2019; 11():4185-4200. PubMed ID: 31190988
[No Abstract] [Full Text] [Related]
12. The Prognostic Value of Decreased LKB1 in Solid Tumors: A Meta-Analysis.
Xiao J; Zou Y; Chen X; Gao Y; Xie M; Lu X; Li W; He B; He S; You S; Chen Q
PLoS One; 2016; 11(4):e0152674. PubMed ID: 27035914
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and Clinicopathological Significance of C-Reactive Protein to Albumin Ratio in Patients With Pancreatic Cancer: A Meta-Analysis.
Xie Q; Wang L; Zheng S
Dose Response; 2020; 18(2):1559325820931290. PubMed ID: 32647499
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment C-reactive protein to albumin ratio for predicting overall survival in advanced pancreatic cancer patients.
Hang J; Xue P; Yang H; Li S; Chen D; Zhu L; Huang W; Ren S; Zhu Y; Wang L
Sci Rep; 2017 Jun; 7(1):2993. PubMed ID: 28592881
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of pre-treatment C-reactive protein/albumin ratio in esophageal cancer: a meta-analysis.
Liu Z; Shi H; Chen L
BMC Cancer; 2019 Nov; 19(1):1161. PubMed ID: 31783812
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of long non-coding RNA UCA1 in human solid tumors.
Liu FT; Zhu PQ; Luo HL; Zhang Y; Qiu C
Oncotarget; 2016 Sep; 7(36):57991-58000. PubMed ID: 27517147
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and clinicopathological significance of C-reactive protein/albumin ratio (CAR) in patients with gastric cancer: A meta-analysis.
Yu J; Liu H; Zeng X; Zhao Y; Jiang D; Lu H; Qian J
PLoS One; 2021; 16(4):e0250295. PubMed ID: 33901218
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of HOXA13 in solid tumors: A meta-analysis.
Wen Y; Shu F; Chen Y; Chen Y; Lan Y; Duan X; Zhao SC; Zeng G
Clin Chim Acta; 2018 Aug; 483():64-68. PubMed ID: 29678634
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of the pretreatment C-reactive protein/albumin ratio in gastric cancer: A systematic review and meta-analysis.
Yang X; Song X; Zhang L; Wu C
Medicine (Baltimore); 2020 Mar; 99(10):e19362. PubMed ID: 32150079
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Effect of Albumin-to-Globulin Ratio in Patients with solid tumors: A Systematic Review and Meta-analysis.
He J; Pan H; Liang W; Xiao D; Chen X; Guo M; He J
J Cancer; 2017; 8(19):4002-4010. PubMed ID: 29187875
[No Abstract] [Full Text] [Related]
[Next] [New Search]
